Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J. B. Schnog"'
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-4 (2024)
Abstract In the PSMAfore randomized controlled trial patients with chemotherapy naïve castrate resistant metastasized prostate cancer (CRPC) progressing after one line of a second-generation androgen receptor signaling inhibitor (ARSI) were randomiz
Externí odkaz:
https://doaj.org/article/a4031c03d2e74df6957d029fa3d56a2a
Publikováno v:
Annals of Hematology, 84(5), 282-286. SPRINGER
In recent years an important role has been ascribed to a reduced nitric oxide (NO) availability in the pathophysiology of sickle cell disease (SCD). Endogenously produced inhibitors of NO synthase, in particular asymmetric dimethylarginine (ADMA), ar
Autor:
Ashley J. Duits, J. B. Schnog, D. P. M. Brandjes, M. R. Mac Gillavry, H. Ten Cate, R.A. Rojer
Publikováno v:
Annals of Hematology. 82:109-113
Cytokines and adhesion molecules play an important role in the pathophysiology of vaso-occlusion in sickle cell disease (SCD), and their in vivo profiles are potential tools for assessing SCD severity. We compared steady-state soluble vascular cell a
Autor:
Ashley J. Duits, R.A. Rojer, L.W. Statius van Eps, D. P. M. Brandjes, J. B. Schnog, H. ten Cate, M. R. Mac Gillavry, F. P. L. van der Dijs, A.P. Kater, L. R. Lard
Publikováno v:
American journal of hematology, 68(3), 179-183. Wiley-Liss Inc.
Vasoocclusion is a continuous process in sickle cell disease (SCD) and accumulates to significant end organ damage, mostly irrespective of the occurrence of manifest acute vasoocclusive events. As there are indications that reversing the hypercoagula
Autor:
Anita W. Rijneveld, J. B. Schnog, Dees P B Brandjes, Erfan Nur, Melvin R. Mac Gillavry, Charlotte F.J. van Tuijn, Marein Schimmel, Eduard J. van Beers, Bart J. Biemond
Publikováno v:
American Journal of Hematology. 90:E75-E76
Autor:
R.A. Rojer, J. B. Schnog, M. R. Mac Gillavry, Rob Fijnheer, D. P. M. Brandjes, Joost C. M. Meijers, Ashley J. Duits, H. ten Cate
Publikováno v:
American journal of hematology, 71(1), 53-55. Wiley-Liss Inc.
Sickle cell patients are characterized by a chronic inflammatory and hypercoagulable state, depicted by elevated levels of pro-inflammatory cytokines, endothelial adhesion molecules, and elevated markers of thrombin generation. We set out to determin
Autor:
J. B. Schnog, Joost C. M. Meijers, Bart J. Biemond, Erfan Nur, Shuena Martina, Dees P. M. Brandjes, Alberto Mantovani, Ivan Cuccovillo, Hans-Martin Otten, Barbara Bottazzi, Eduard J. van Beers
Publikováno v:
Blood cells, molecules & diseases, 46(3), 189-194. Academic Press Inc.
The painful crisis accounts for the majority of sickle cell disease (SCD) related hospital admissions. The prototypic long pentraxin 3 (PTX3), an acute phase protein, is elevated in patients with inflammatory and ischemic states. As the sickle cell p
Autor:
J. B. Schnog, Ashley J. Duits, Henri M. H. Spronk, E. van Beers, D. P. M. Brandjes, J W J van Esser, Bart J. Biemond, H. ten Cate
Publikováno v:
Haematologica, 93(5), e42-e44. Ferrata Storti Foundation
Pulmonary hypertension (PHT) occurs in approximately 30% of adult patients with sickle cell disease (SCD) and is a risk factor for early death.[1][1] Hypercoagulability has been linked to PHT in general and pulmonary artery thrombosis contributes to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e0a7227a3b7698335d44f77eb70899
https://pure.amc.nl/en/publications/no-association-of-the-hypercoagulable-state-with-sickle-cell-disease-related-pulmonary-hypertension(b3c70a9d-5c51-4fb0-9e37-cbb1de7d9c49).html
https://pure.amc.nl/en/publications/no-association-of-the-hypercoagulable-state-with-sickle-cell-disease-related-pulmonary-hypertension(b3c70a9d-5c51-4fb0-9e37-cbb1de7d9c49).html
Publikováno v:
The Netherlands journal of medicine. 62(10)
Sickle cell disease (SCD) is a heterogeneous disorder, with clinical manifestations including chronic haemolysis, an increased susceptibility to infections and vaso-occlusive complications often requiring medical care. Patients with SCD can develop s
Autor:
Ashley J. Duits, J. B. Schnog, T. van Endt, D. P. M. Brandjes, H. Ten Cate, R.A. Rojer, M. R. Mac Gillavry
Publikováno v:
Annals of hematology. 82(3)
Sickle cell patients are characterized by stress erythropoiesis involving cytokines, growth factors, and adhesion molecules. We set out to determine whether serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels, which are inversely related